JOHN HOPE FRANKLIN CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.duke.edu
Levetiracetam in Post-Traumatic Stress Disorder
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2014-07-21
- Lead Sponsor
- Duke University
- Target Recruit Count
- 16
- Registration Number
- NCT00413296
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-11-30
- Last Posted Date
- 2014-07-11
- Lead Sponsor
- Duke University
- Target Recruit Count
- 23
- Registration Number
- NCT00405678
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow Velocity
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-11-22
- Last Posted Date
- 2013-06-19
- Lead Sponsor
- Duke University
- Target Recruit Count
- 50
- Registration Number
- NCT00402480
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
- First Posted Date
- 2006-11-15
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- Duke University
- Target Recruit Count
- 5
- Registration Number
- NCT00399893
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Antidepressant Safety in Kids Study
- First Posted Date
- 2006-11-02
- Last Posted Date
- 2015-04-17
- Lead Sponsor
- Duke University
- Target Recruit Count
- 569
- Registration Number
- NCT00395213
- Locations
- 🇺🇸
Child and Adolescent Psychiatry Trials Network (CAPTN), Durham, North Carolina, United States
Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-10-13
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- Duke University
- Target Recruit Count
- 37
- Registration Number
- NCT00387933
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients
- First Posted Date
- 2006-08-29
- Last Posted Date
- 2013-04-11
- Lead Sponsor
- Duke University
- Target Recruit Count
- 4
- Registration Number
- NCT00369603
- Locations
- 🇺🇸
Joseph & Kathleen Bryan Alzheimer's Disease Research Unit, Durham, North Carolina, United States
Showing Health Information Value in a Community Network
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-08-18
- Last Posted Date
- 2014-07-11
- Lead Sponsor
- Duke University
- Target Recruit Count
- 20108
- Registration Number
- NCT00365885
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Study of the Insomnia in Patients With Low Back Pain
- First Posted Date
- 2006-08-18
- Last Posted Date
- 2015-07-24
- Lead Sponsor
- Duke University
- Target Recruit Count
- 58
- Registration Number
- NCT00365976
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2014-07-10
- Lead Sponsor
- Duke University
- Target Recruit Count
- 52
- Registration Number
- NCT00362921
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
© Copyright 2024. All Rights Reserved by MedPath